• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medications during pregnancy and nursing is a challenge for women suffering from the condition. There is a lack of information about how long-term exposure to these drugs may affect the foetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues like hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medications must weigh the advantages of taking them against potential risks to the fetus. Physicians do not have the information needed to give clear guidelines, but they can provide information regarding the risks and benefits to help pregnant women make informed choices.

A study published in Molecular Psychiatry found that women who were taking ADHD medications in early pregnancy did not have a significantly increased risk of fetal cardiac malformations or major structural birth defects. Researchers used a vast population-based case-control study to determine the prevalence of major structural birth defects in babies born to mothers who had taken stimulants in the early stages of pregnancy, as well as those who had not. Clinical geneticists and pediatric cardiologists looked over the cases to ensure correct case classification and to minimize the chance of bias.

The study conducted by the researchers was not without its limitations. Researchers were unable in the beginning to differentiate the effects of the medication from the disorder. This makes it difficult for researchers to determine if the few associations observed between the groups that were exposed to medication use, or if they were affected by the presence of comorbidities. The researchers did not look at long-term outcomes for the offspring.

The study did reveal that babies whose mothers had taken ADHD medications during pregnancy were at slightly higher risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or stopped their medications before or during pregnancy. This was due to central nervous system-related disorders and the increased risk for admission did not appear to be influenced by which stimulant medications were used during pregnancy.

Women who took stimulant ADHD medication during pregnancy were also at an elevated risk of having a caesarean section or having a baby born with low Apgar score (less than 7). These increases appear to be independent of the type of medication used during pregnancy.

The research suggests that the low risk associated with the use of managing adhd without medication medications during early pregnancy could be offset by the greater benefit to both mother and child of continuing treatment for the woman's condition. Physicians should talk to their patients about this issue and, if possible, help them improve coping skills which may reduce the impact of her disorder in her daily life and relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and treated with medication, the dilemma of whether to continue or discontinue treatment during pregnancy is a question that doctors are having to face. The majority of these decisions are taken in the absence of clear and authoritative evidence in either case, which means that doctors must weigh what they know from their own experiences, those of other doctors, and what the research says on the topic, along with their own best judgment for each individual patient.

The issue of potential risks to infants is difficult to determine. The research on this subject is based on observations rather than controlled studies and the results are conflicting. In addition, most studies limit their analysis to live births, which can underestimate the severity of teratogenic effects that could lead to abortion or termination of the pregnancy. The study presented in this journal club addresses these issues by analyzing data on live and deceased births.

The conclusion: While some studies have shown an association between ADHD medications and the possibility of certain birth defects, others have found no such relationship, and most studies demonstrate a neutral or slightly negative impact. In every case an in-depth study of the potential risks and benefits must be performed.

It isn't easy, but not impossible, for women with ADHD to stop taking their medication. In a recent article published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping treating adhd without medication medications during pregnancy can lead to depression and feelings of isolation. Additionally, the loss of medication can interfere with the ability to complete jobs and drive safely, which are important aspects of daily life for many people suffering from ADHD.

She recommends that women who are unsure about whether to keep or stop medication in light of their pregnancy consider educating family members, friends and colleagues about the condition, its impact on daily life, and the advantages of continuing the current treatment plan. It can also help a woman feel supported in her decision. Some medications can pass through the placenta. If a patient decides to not take her ADHD medication while pregnant and breastfeeding, it is crucial to be aware that the drug could be transferred to the infant.

Birth Defects and Risk of

As the use and abuse of ADHD medication to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases as does the concern about the possible effects of the drugs on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this topic. Researchers used two massive data sets to examine over 4.3 million pregnancies and determine whether stimulant medications increased birth defects. Although the risk overall remains low, the scientists found that exposure in the first trimester to ADHD medications was associated with a slightly higher rate of specific heart defects, such as ventriculoseptal defect (VSD).

The researchers of the study did not discover any connection between the use of early medications and congenital anomalies like facial deformities or club feet. The results are consistent with previous studies that have shown the presence of a small, but significant increase in the risk of developing cardiac malformations in women who started taking ADHD medications before the time of pregnancy. The risk grew in the latter half of pregnancy, when many women decide to stop taking their ADHD medication.

Women who took ADHD medication during the first trimester were more likely to require a caesarean delivery and also have a low Apgar after delivery and have a baby that needed breathing assistance at birth. The authors of the study were unable to remove bias in selection since they limited the study to women without other medical conditions that might have contributed to the findings.

Researchers hope that their research will help doctors when they encounter pregnant women. They suggest that although a discussion of the risks and benefits is crucial however, the decision to stop or continue treatment should be based on the woman's needs and the severity of her ADHD symptoms.

The authors caution that, although stopping the medication is a possibility to think about, it isn't advised because of the high incidence of depression and other mental problems in women who are expecting or recently gave birth. Additionally, research suggests that women who stop taking their medication will have a tough adjustment to life without them after the baby is born.

Nursing

It can be a stressful experience to become a mom. Women with ADHD who must work through their symptoms while attending physician appointments as well as preparing for the arrival of a child and getting used to new routines at home may face a lot of challenges. Many women decide to continue taking their ADHD medication during pregnancy.

The majority of stimulant drugs are absorbed by breast milk in small amounts, so the risk to breastfeeding infant is minimal. However, the frequency of exposure to medications by the newborn can vary depending on dosage, frequency it is administered, and at what time the medication is administered. Additionally, different medications enter the baby's system differently through the gastrointestinal tract as well as breast milk and the impact of this on a newborn infant is not yet fully known.

Due to the absence of evidence, some doctors may be inclined to discontinue stimulant medications during a woman's pregnancy. It's a difficult choice for the mother, who must weigh the benefits of her medication against the potential risks to the foetus. In the meantime, until more information is available, doctors may inquire about pregnant patients if they have an history of ADHD or if they are planning to take medication in the perinatal period.

Numerous studies have proven that women can you get adhd medication without a Diagnosis (yogicentral.science) continue taking their ADHD medication safely during pregnancy and breast-feeding. This has led to many patients choose to do so, and in consultation with their physician, they have found that the benefits of keeping their current medication outweigh any risks.

Women who suffer from ADHD who plan to breastfeed should seek the advice of an expert psychiatrist prior to becoming pregnant. They should discuss their medication with their prescriber and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological strategies. Psychoeducation is also necessary to help pregnant women suffering from ADHD recognize the signs and underlying disorder. They should also be informed about treatment options and reinforce the coping mechanisms. This should be a multidisciplinary process together with obstetricians, GPs and psychiatry. Pregnancy counselling should include discussion of a management plan for both the mother and child, and monitoring for signs of deterioration, and, if necessary, adjustments to the medication regimen.